Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

Metastasis continues to be the primary cause of all cancer-related deaths despite the recent advancements in cancer treatments. To evaluate the role of mutations in overall survival (OS) and treatment outcomes, we analyzed 957 metastatic patients with seven major cancer types who had available molec...

Full description

Bibliographic Details
Main Authors: Moom R. Roosan, Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Angel R. Baroz, Joseph Chao, Chen Chen, Mohd W. Nasser, Ramakanth Chirravuri-Venkata, Maneesh Jain, Lynette Smith, Susan E. Yost, Karen L. Reckamp, Raju Pillai, Leonidas Arvanitis, Michelle Afkhami, Edward W. Wang, Vincent Chung, Mihaela Cristea, Marwan Fakih, Marianna Koczywas, Erminia Massarelli, Joanne Mortimer, Yuan Yuan, Surinder K. Batra, Sumanta Pal, Ravi Salgia
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
metastatic solid tumors
somatic mutations
overall survival
progression-free survival
molecular testing
targeted therapies
Online Access:https://www.mdpi.com/2072-6694/13/11/2776

Internet

https://www.mdpi.com/2072-6694/13/11/2776

Similar Items